Interactions between spironolactone and Dextrose 10 and electrolyte no 48 (LVP solution with potassium)
spironolactone and LVP solution with potassium (Major Drug-Drug)
MANAGEMENT: If this combination is used, patients should be monitored very closely for hyperkalemia. Patients should be given dietary counseling and advised to report any possible symptoms of hyperkalemia such as weakness, listlessness, confusion, tingling of the extremities, or feelings of heaviness in the legs to their physician.





